Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.

MLA

Gao, Rui-Qian, et al. “Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.” Journal of Oncology, vol. 2023, Feb. 2023, p. 1875153. EBSCOhost, https://doi.org/10.1155/2023/1875153.

APA

Gao, R.-Q., Sun, J.-H., Ma, Y.-H., Xie, Y.-W., Shao, G.-M., Wang, C., Tan, B., Liu, K., Li, K., Li, N., Hu, W.-Y., & Cao, J. (2023). Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery. Journal of Oncology, 2023, 1875153. https://doi.org/10.1155/2023/1875153

Chicago

Gao, Rui-Qian, Jing-Han Sun, Yong-Hui Ma, Yu-Wei Xie, Guan-Ming Shao, Cong Wang, Bin Tan, et al. 2023. “Circulating the HLA-DR+ T Cell Ratio Is a Prognostic Factor for Recurrence of Patients with Hepatocellular Carcinoma after Curative Surgery.” Journal of Oncology 2023 (February): 1875153. doi:10.1155/2023/1875153.